Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cefepime (2gm) + Tazobactum (250mg) Injection
Therapeutic Category
Antibiotic, Antibacterials
Dosage Form
Injection
Packaging Type
Vial
Packaging
2.25gm
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Tillpime TZ 2.25 Injection is a powerful combination of Cefepime (2gm) and Tazobactam (250mg). Cefepime is a fourth-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, effectively killing a wide range of Gram-positive and Gram-negative bacteria. Tazobactam is a beta-lactamase inhibitor that protects Cefepime from being broken down by resistant bacteria, thereby enhancing its antibacterial action.
It helps in the treatment of severe and hospital-acquired infections, including lower respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and septicemia. This combination is especially useful when dealing with multi-drug resistant organisms.
Common side effects may include injection site pain, nausea, vomiting, diarrhea, or skin rash. Rarely, patients may experience allergic reactions, liver enzyme changes, or blood count abnormalities.
Used for treating serious bacterial infections in the lungs, urinary tract, abdomen, skin, and bloodstream. It is particularly indicated in cases where resistance to other antibiotics is suspected or confirmed.
To be administered only under strict medical supervision in a hospital or clinical setting. Complete the full course as prescribed. Dose adjustment may be required in patients with kidney impairment.
Store in a cool, dry place below 25°C. Protect from direct light. Use immediately after reconstitution or as directed by a healthcare professional. Keep out of reach of children.
Composition : Cefepime (1000mg) Injection
Composition : Cefepime (250mg)
Composition : Cefepime (1000mg) + Tazobactum (125mg)
Composition : Cefepime (1gm) + Sulbactum (500mg)
Composition : Tigecycline (50mg) Injection
Composition : Teicoplanin (400mg) Injection
Composition : Cefoperazone (1000mg) + Sulbactam (500mg)
Composition : Ceftazidime (1000mg) + Tazobactum (125mg)
Composition : Moxifloxacin IP 400 mg + Mannitol IP 5.0% w/v Infusuion
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Cefepime 2gm + Tazobactam 250mg Injection has strong demand in the critical care and hospital antibiotic segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from the high requirement of this combination in severe and resistant bacterial infections. Including this product helps strengthen their injectable antibiotic and critical care portfolio.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Cefepime 2gm + Tazobactam 250mg Injection with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from attractive business margins, timely product availability, professional marketing support, and access to a trusted advanced injectable antibiotic range when partnering with Cafoli Lifecare for this combination injection.
Medical distributors, stockists, wholesalers, and pharma professionals interested in Cefepime 2gm + Tazobactam 250mg Injection can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.